Octapharma USA, Inc.
Snehal Udavat has extensive experience in clinical operations, currently serving as Associate Director of Clinical Operations at Octapharma USA, Inc. since August 2014. Prior roles at Octapharma include Clinical Project Manager, Clinical Study Manager, Clinical Research Associate, and Clinical Trial Associate. Before Octapharma, Snehal worked at Merck from May 2009 to September 2014 as a Clinical Documentation Specialist, where responsibilities included managing Trial Master File documents for various clinical trial phases. Earlier professional experience includes positions as a Teller at Valley National Bank and a Computer Consultant at Rutgers University. Snehal holds a Bachelor's degree in Cell Biology and Neuroscience from Rutgers University, obtained in 2006.
This person is not in any teams
Octapharma USA, Inc.
1 followers
Octapharma USA, headquartered in Paramus, N.J., is a subsidiary of Octapharma AG, a global human protein products powerhouse, dedicated to the research and manufacture of human proteins. We have been committed to patient care and medical innovation for 40 years. Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year.